雾化吸入疗法急诊临床应用专家共识（2018）

doi:10.3969/j.issn.1002-1949.2018.07.002

Chinese Journal of Critical Care Medicine

2018, Vol. 38

Issue (7): 565-574 DOI: 10.3969/j.issn.1002-1949.2018.07.002

Abstract
Figure/Table
References (43)
Related Citation (15)

［1］Elliott D, Dunne P. Guide to aerosol delivery devices for physicians, nurses, pharmacists, and other health care professionals［J］. Am Assoc Resp Care, 2011： 1-64. ［2］Ibrahim M, Verma R, Garcia-Contreras L, et al. Inhalation drug delivery devices: technology update［J］. Med Devices (Auckl), 2015, 8:131-139. ［3］中华医学会呼吸病学分会《雾化吸入疗法在呼吸疾病中的应用专家共识》制定专家组. 雾化吸入疗法在呼吸疾病中的应用专家共识［J］. 中华医学杂志， 2016， 96(34): 2696-2708. ［4］于启林，朱士俊，梁爱萍，等. 82598例急诊患者疾病分类调查［J］. 中华医院管理杂志， 2001， 17(10): 599-601. ［5］郝璐，尹文，黄杨，等. 55650例急诊病例疾病谱分析及护理对策［J］. 护理学杂志， 2008， 23(5): 32-34. ［6］Trnjar K, PintaricS, Mornar JelavicM, et al. Correlation Between Occurrence and Deterioration of Respiratory Diseases and Air Pollution Within the Legally Permissible Limits［J］. Acta Clin Croat, 2017, 56(2): 210-217. ［7］Zhang H, Niu Y, Yao Y, et al. The Impact of Ambient Air Pollution on Daily Hospital Visits for Various Respiratory Diseases and the Relevant Medical Expenditures in Shanghai, China［J］. Int J Environ Res Public Health, 2018, 15(3). pii: E425. ［8］Zhu Z, Zheng J, Wu Z, et al. Clinical practice of nebulized therapy in China: a national questionnaire survey［J］. J Aerosol Med Pulm Drug Deliv, 2014, 27(5): 386-391. ［9］Martin AR, Finlay WH. Nebulizers for drug delivery to the lungs［J］. Expert Opin Drug Deliv, 2015, 12(6): 889-900. ［10］Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology［J］. Chest, 2005, 127(1): 335-371. ［11］中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南（2016年版）［J］. 中华结核和呼吸杂志， 2016， 39(9): 675-697.［12］申昆玲，邓力，李云珠，等. 糖皮质激素雾化吸入疗法在儿科应用的专家共识(2018年修订版)［J］. 临床儿科杂志， 2018， 36(2): 95-107. ［13］Dahlstrm K, Thorsson L, Larsson P, et al. Systemic availability and lung deposition of budesonide via three different nebulizers in adults［J］. Ann Allergy Asthma Immunol, 2003, 90(2): 226-232. ［14］Chen AH, Zeng GQ, Chen RC, et al. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study［J］. Respirology, 2013, 18（Suppl 3）: 47-52. ［15］支修益，卫生部临床路径专家委员会胸外科专家组. 胸外科围手术期气道管理专家共识(2012年版)［J］. 中国胸心血管外科临床杂志， 2013， 20(3): 251-255. ［16］多学科围手术期气道管理专家共识(2016年版)专家组. 多学科围手术期气道管理专家共识(2016年版)［J］. 中华胸部外科电子杂志， 2016， 3(3): 129-133. ［17］Sun X, He Z, Zhang J, et al. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD［J］. Pulm Pharmacol Ther, 2015, 31（1）: 111-116. ［18］Brattsand R, Miler-Larsson. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity［J］. Clin Ther, 2003, 25 （Suppl C）: C28-C41. ［19］Zhou J, Liu DF, Liu C, et al. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism［J］. Allergy, 2008, 63(9): 1177-1185. ［20］Mendes ES, Rebolledo, Campos M, et al. Immediate antiinflammatory effects of inhaled budesonide in patients with asthma［J］. Ann Am Thorac Soc, 2014, 11(5): 706-711. ［21］Tsai YG, Lee MY, Yang KD, et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma［J］. J Pediatr, 2001, 139(3): 433-437. ［22］成人慢性气道疾病雾化吸入治疗专家组. 成人慢性气道疾病雾化吸入治疗专家共识［J］. 中国呼吸与危重监护杂志, 2012， 11(2): 105-110. ［23］中华医学会呼吸病学分会哮喘学组，中国哮喘联盟. 支气管哮喘急性发作评估及处理中国专家共识［J］. 中华内科杂志， 2018， 57(1): 4-14. ［24］刘海英，邱林. 急性喉梗阻的急救护理［J］. 中国医药指南， 2016， 14(32): 271-272. ［25］中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南(2015)［J］. 中华结核和呼吸杂志， 2016， 39(5): 323-354. ［26］赖克方，刘宝娟. 激素敏感性咳嗽的临床特征与治疗［J］. 中国临床医生， 2014， 42(7): 8-10. ［27］中国医师协会急诊医师分会. 急诊成人社区获得性肺炎诊治专家共识(一)［J］. 中国急救医学， 2011， 31(10): 865-871. ［28］Rello J, Solé-Lleonart C, Rouby JJ, et al. Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases［J］. Clin Microbiol Infect, 2017, 23(9): 629-639. ［29］中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识［J］. 中国急救医学， 2016， 36(2): 97-107. ［30］慢性气道炎症性疾病气道黏液高分泌管理中国专家共识编写组. 慢性气道炎症性疾病气道黏液高分泌管理中国专家共识［J］. 中华结核和呼吸杂志， 2015， 38(10): 723-729. ［31］Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses［J］. Eur J Epidemiol, 2010, 25(9): 603-605. ［32］Elamin E, Miller A. Impact of nebulized unfractionated heparin and N-acetylcysteine in management of smoke inhalation injury［J］. Crit Care, 2009, 13(Suppl 1): 438. ［33］Hashemian SM, Mortaz E, Jamaati H, et al. Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells［J］. J Crit Care, 2018, 44: 161-167. ［34］Mohamed H S, Meguid MM. Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury/acute respiratory distress syndrome: Randomized controlled study［J］. Saudi J Anaesth, 2017, 11(1): 9-14. ［35］Davidson AC, Banham S, Eliott M, et al. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults［J］. Thorax, 2016, 71（Suppl 2）: ii1-35. ［36］Khemani RG, Randolph A, Markovitz B. Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults［J］. Cochrane Database Syst Rev, 2009, 8(3): CD001000. ［37］Franois B, Bellisant E, Gissot V, et al. 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial［J］. Lancet, 2007, 369(9567): 1083-1089. ［38］Kashefi P, Abbasi A, Abbasi M, et al. Comparison of the efficacy of nebulized budesonide and intravenous dexamethasone administration before extubation in prevention of post-extubation complications among patients admitted in intensive care unit［J］. Adv Biomed Res, 2015, 4: 11. ［39］Arulparithi CS, Babu TA, Ravichandran C, et al. Efficacy of nebulised budesonide versus oral prednisolone in acute severe asthma［J］. Indian J Pediatr, 2015, 82(4): 328-332. ［40］中华医学会呼吸病学分会哮喘学组，中国哮喘联盟. 重症哮喘诊断与处理中国专家共识［J］. 中华结核和呼吸杂志， 2017， 40(11): 813-829. ［41］Harris L. Comparison of cardiorespiratory effects of terbutaline and salbutamol aerosols in patients with reversible airways obstruction［J］. Thorax, 1973, 28(5): 592-595. ［42］Cazzola M, Page CP, Calzetta L, et al. Pharmacology and therapeutics of bronchodilators［J］. Pharmacol Rev, 2012, 64(3): 450-504. ［43］中华医学会儿科学分会呼吸学组，《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016年版)［J］. 中华儿科杂志， 2016， 54(3): 167-181.